Nimotuzumab plus radiotherapy for unresectable squamous-cell carcinoma of the head and neck-Reference-Cited by-同舟云学术

Nimotuzumab plus radiotherapy for unresectable squamous-cell carcinoma of the head and neck

Published:2010-03 Issue:5 Volume:9 Page:343-349
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Rodríguez Marta Osorio,Rivero Teresa Cruz,Del Castillo Bahi Ramón,Muchuli Carlos Roca,Bilbao Miguel Azcue,Vinageras Elia Neninger,Alert José,Galainena Julio Jiménez,Rodríguez Edmundo,Gracia Elías,Mulén Bárbara,Wilkinson Bárbara,de Armas Esther Lucía,Pérez Kirenia,Pineda Idael,Frómeta Milagros,Leonard Idrissa,Mullens Vladimir,Viada Carmen,Luaces Patricia,Torres Olga,Iznaga Normando,Crombet Tania

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.4161/cbt.9.5.10981

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Nimotuzumab in Combination with Radiotherapy or Chemoradiotherapy for Local Advanced Head and Neck Cancer: A Systematic Review and Meta-analysis;Current Cancer Drug Targets;2024-09

2. Epidermal growth factor receptor‑targeted antibody nimotuzumab combined with chemoradiotherapy improves survival in patients with locally advanced head and neck squamous cell carcinoma: a propensity score matching real‐world study;MedComm;2024-07

3. Nimotuzumab combined with radiotherapy+/- chemotherapy for definitive treatment of locally advanced squamous cell carcinoma of head and neck: a metanalysis of randomized controlled trials;Frontiers in Oncology;2024-06-13

4. A Network Meta-Analysis of the Systemic Therapies in Unresectable Head and Neck Squamous Cell Carcinoma;Cancer Control;2024-01

5. Indian clinical practice consensus guidelines for the management of laryngeal cancer: Update 2022;Cancer Research, Statistics, and Treatment;2024-01